c-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action
- 149 Downloads
Endometriosis is an estrogen-dependent disease, causing pelvic pain and infertility. c-fos is an early transcription factor that has been reported to be related to estradiol-dependent cell proliferation. The aim of the present study was to assess the c-fos gene and protein expression in pelvic endometriotic implants in comparison to normal endometrium from infertile women. An open, prospective and controlled study included 15 infertile women with endometriosis and 19 control infertile women. Endometrial and endometriotic biopsies were performed at the follicular phase and the samples were processed for RT-PCR and immunohistochemistry. ERα mRNA levels were similar in the endometriotic implants/eutopic endometrium from women with endometriosis and in normal tissue (P = 0.649). The aromatase gene, however, was not expressed in the eutopic endometrium from either control or endometriosis groups, and was only expressed in 50% of endometriotic implants (P = 0.044). c-fos gene expression was higher in endometriotic implants (1.32 ± 0.13; P = 0.011) than in eutopic endometrium from patients with endometriosis (0.97 ± 0.11) or from the control group (0.91 ± 0.05). In addition, immunohistochemistry showed a more abundant distribution of c-Fos in the stroma of endometriotic tissue compared to eutopic endometrium. These data suggest that c-fos may play a role in the molecular mechanisms of estrogen action on the induction, promotion or progression of endometriosis.
KeywordsEndometriosis Estrogen c-fos Gene expression Aromatase
This study was supported by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Programa de Apoio aos Núcleos de Excelência em Pesquisa (PRONEX).
- Asschert JG, De Vries EG, De Jong S, Withoff S, Vellenga E (1999) Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1. Int J Cancer 81:236–242. doi: 10.1002/(SICI)1097-0215(19990412)81:2<;236::AID-IJC12>;3.0.CO;2-R PubMedCrossRefGoogle Scholar
- Fujishita A, Nakane PK, Koji T, Masuzaki H, Chavez RO, Yamabe T et al (1997) Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil Steril 67:856–864. doi: 10.1016/S0015-0282(97)81397-0 PubMedCrossRefGoogle Scholar
- Matsuzaki S, Uehara S, Murakami T, Fujiwara J, Funato T, Okamura K (2000) Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay. Fertil Steril 74:753–759. doi: 10.1016/S0015-0282(00)00712-3 PubMedCrossRefGoogle Scholar
- Othman EE, Salama S, Ismail N, Al-Hendy A (2007) Toward gene therapy of endometriosis: adenovirus-mediated delivery of dominant negative estrogen receptor genes inhibits cell proliferation, reduces cytokine production, and induces apoptosis of endometriotic cells. Fertil Steril 88:462–471. doi: 10.1016/j.fertnstert.2006.11.046 PubMedCrossRefGoogle Scholar
- Pan H, Sheng JZ, Tang L, Zhu R, Zhou TH, Huang HF (2008) Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients. Fertil Steril 90:1000–1007. doi: 10.1016/j.fertnstert.2007.07.1386 PubMedCrossRefGoogle Scholar
- Sampson JA (1927) Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–425Google Scholar